WebJun 26, 2013 · The ongoing EAST (Early treatment of atrial fibrillation for stroke prevention trial) study (4) is currently testing whether early use of rhythm control therapy can prevent adverse cardiovascular outcomes in patients with AF compared to usual care. ISSUE (international study on syncope of uncertain aetiology) WebAug 21, 2024 · Abstract Aims: Atrial fibrillation (AF) is a progressive disease. Targeted therapy of underlying conditions refers to interventions aiming to modify risk factors in order to prevent AF. We hypothesised that targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent AF.
Did you know?
WebJul 30, 2024 · Methods: This prespecified subanalysis of the randomized EAST-AFNET4 trial (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) assessed the effect of systematic, early rhythm control therapy (ERC; using antiarrhythmic drugs or catheter ablation) compared with usual care (allowing rhythm control therapy to improve … WebThe STOP AF Post Approval Study (PAS) is the largest prospective FDA multicenter study in North America to assess long-term safety and effectiveness of the Arctic Front …
WebNov 23, 2024 · The AFEQT is a 21-item, AF-specific health-related QOL questionnaire that assesses the impact of AF on patient-reported quality of life. The AFEQT includes a summary score (calculated from 18 of the questions) and subscale scores in three domains: symptoms, daily activities, and treatment concern. WebFeb 2, 2011 · Study Description Go to Brief Summary: EAST prospectively tests the hypothesis that an early, structured rhythm control therapy based on antiarrhythmic …
WebMar 15, 2024 · The squares represent the hazard ratios and the bars indicate the 95% CIs. AF indicates atrial fibrillation; CHA 2 DS 2-VASc, congestive heart failure, hypertension, age ≥75 years (doubled), diabetes, stroke/transient ischemic attack/thromboembolism (doubled), vascular disease (prior myocardial infarction, peripheral artery disease, or … WebNov 16, 2024 · The median percentage of time in atrial fibrillation was 0% (interquartile range, 0 to 0.08) with ablation and 0.13% (interquartile range, 0 to 1.60) with antiarrhythmic drugs. Serious adverse...
WebMay 9, 2024 · Background: Warfarin has long been the only oral anticoagulant (OAC) available, but options now include non-vitamin K antagonists. Prescribing an OAC may be influenced by patient factors and preferences influenced by dosing, monitoring, and adverse effects, which may ultimately impact patient satisfaction and convenience. The aim of …
WebApr 27, 2024 · Disclosures. EAST-AFNET 4 was supported by a grant from the German Ministry of Education and Research, the German Center for Cardiovascular Research (DZHK), the Atrial Fibrillation Network (AFNET), the European Heart Rhythm Association, St. Jude Medical – Abbott, Sanofi, the German Heart Foundation, the European Union, … crystic 199 resinWebOct 22, 2024 · Aim The aim of this study is to investigate whether, in older overweight/obese AF patients, referral to a weight loss programme with meal … crystic 196WebFeb 1, 2015 · The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial Eur … dynamics crm trial environmentWebApr 13, 2024 · According to the research, the first mainshock happened around 4:18 a.m. local time and had a moment magnitude (Mw) of 7.95. About nine hours later, a second earthquake struck to the north, with ... crystic 356paWebEAST - AFNET 4 results. Early rhythm control therapy improves outcomes in patients with atrial fibrillation. Patients with newly diagnosed atrial fibrillation (AF) benefit from early … crystic 397paWebJul 30, 2024 · This prespecified subanalysis of the randomized EAST-AFNET4 trial (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial) assessed the effect of systematic, early rhythm control therapy (ERC; using antiarrhythmic drugs or catheter ablation) compared with usual care (allowing rhythm control therapy to improve … crystic 399WebDec 4, 2024 · EAST-AFNET 4 (Early Treatment of Atrial Fibrillation for Stroke Prevention Trial), an international, randomized, open, blinded outcome assessment trial, was … crystic 2.8500pa